Cornerstone Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-482,700
| Closed | -$12M | – | 148 |
|
|
2025
Q4 | $12M | Hold |
482,700
| – | – | 0.4% | 74 |
|
|
2025
Q3 | $12.3M | Sell |
482,700
-10,000
| -2% | -$247K | 0.41% | 60 |
|
|
2025
Q2 | $11.9M | Buy |
492,700
+245,300
| +99% | +$5.72M | 0.41% | 66 |
|
|
2025
Q1 | $6.27M | Hold |
247,400
| – | – | 0.27% | 94 |
|
|
2024
Q4 | $6.56M | Hold |
247,400
| – | – | 0.26% | 91 |
|
|
2024
Q3 | $7.16M | Hold |
247,400
| – | – | 0.28% | 87 |
|
|
2024
Q2 | $6.92M | Sell |
247,400
-400
| -0.2% | -$11K | 0.28% | 93 |
|
|
2024
Q1 | $6.88M | Buy |
247,800
+5,300
| +2% | +$147K | 0.28% | 93 |
|
|
2023
Q4 | $6.98M | Sell |
242,500
-19,800
| -8% | -$599K | 0.31% | 84 |
|
|
2023
Q3 | $8.7M | Buy |
262,300
+19,600
| +8% | +$693K | 0.41% | 61 |
|
|
2023
Q2 | $8.9M | Buy |
242,700
+202,900
| +510% | +$7.9M | 0.42% | 66 |
|
|
2023
Q1 | $1.62M | Hold |
39,800
| – | – | 0.08% | 156 |
|
|
2022
Q4 | $2.04M | Sell |
39,800
-465,000
| -92% | -$22.3M | 0.1% | 150 |
|
|
2022
Q3 | $22.1M | Buy |
504,800
+94,700
| +23% | +$4.6M | 1.08% | 21 |
|
|
2022
Q2 | $21.5M | Buy |
+410,100
| New | +$20.9M | 1.13% | 16 |
|
|
2020
Q4 | – | Sell |
-226,610
| Closed | -$7.89M | – | 196 |
|
|
2020
Q3 | $7.89M | Sell |
226,610
-15,810
| -7% | -$554K | 0.71% | 32 |
|
|
2020
Q2 | $7.52M | Hold |
242,420
| – | – | 0.7% | 35 |
|
|
2020
Q1 | $7.51M | Sell |
242,420
-20,026
| -8% | -$682K | 0.83% | 33 |
|
|
2019
Q4 | $9.76M | Buy |
+262,446
| New | +$9.35M | 0.8% | 36 |
|
|
2019
Q1 | $20.6M | Sell |
510,136
-94,860
| -16% | -$3.8M | 1.66% | 15 |
|
|
2018
Q4 | $25.1M | Hold |
604,996
| – | – | 2.2% | 6 |
|
|
2018
Q3 | $25.3M | Buy |
+604,996
| New | +$23.3M | 1.82% | 8 |
|
|
2017
Q2 | – | Sell |
-204,160
| Closed | -$6.63M | – | 257 |
|
|
2017
Q1 | $6.63M | Hold |
204,160
| – | – | 1.2% | 23 |
|
|
2016
Q4 | $6.29M | Buy |
204,160
+167,902
| +463% | +$5.13M | 1.16% | 24 |
|
|
2016
Q3 | $1.17M | Buy |
+36,258
| New | +$1.21M | 0.3% | 89 |
|
|
2015
Q2 | – | Sell |
-16,297
| Closed | -$538K | – | 236 |
|
|
2015
Q1 | $538K | Sell |
16,297
-48,484
| -75% | -$1.54M | 0.11% | 171 |
|
|
2014
Q4 | $1.92M | Hold |
64,781
| – | – | 0.38% | 73 |
|
|
2014
Q3 | $1.82M | Hold |
64,781
| – | – | 0.36% | 82 |
|
|
2014
Q2 | $1.82M | Hold |
64,781
| – | – | 0.36% | 86 |
|
|
2014
Q1 | $1.97M | Buy |
64,781
+31,620
| +95% | +$943K | 0.46% | 65 |
|
|
2013
Q4 | $964K | Buy |
33,161
+15,810
| +91% | +$460K | 0.24% | 123 |
|
|
2013
Q3 | $473K | Hold |
17,351
| – | – | 0.15% | 155 |
|
|
2013
Q2 | $461K | Buy |
+17,351
| New | +$479K | 0.18% | 139 |
|
Other funds holding PFE
VCM
VPM
Cornerstone Advisors's PFE Position: Q1 2026 in Review
Cornerstone Advisors sold out of Pfizer (PFE) in Q1 2026, closing a stake of 482,700 shares — an estimated $12M sold.
Cornerstone Advisors first reported a position in PFE in Q2 2013 and held it in 33 quarters. The position peaked at $25.3M in Q3 2018. 2,946 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Cornerstone Advisors reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
- Cornerstone Advisors sold 482,700 Pfizer shares in Q1 2026, an estimated $12M.
- Cornerstone Advisors first reported a position in Pfizer in Q2 2013 and held it in 33 quarters.
- Cornerstone Advisors's Pfizer position peaked at $25.3M in Q3 2018.
- 2,946 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Cornerstone Advisors's 13F filing for Q1 2026, filed 8 May 2026.